Outsourcing-Pharma and Nina Vas, Marken’s Vice President, Clinical Distribution, Cell and Gene Therapy Supply Chain, discuss the specific requirements involved in the clinical trial supply chain for cell and gene therapies and other personalized medicines.

These differ dramatically from small molecule therapies and require an appropriately personalized approach.